The INCORRECT Statement is C
Statement C is incorrect: When replacing the mitral valve in individuals under 50 years of age, a mechanical valve—not a bioprosthetic valve—should be preferred due to the high rate of structural valve deterioration in younger patients.
Analysis of Each Statement
A) Bioprosthetic valves do not require long-term anticoagulation - CORRECT
Bioprosthetic valves generally do not require long-term anticoagulation beyond the initial 3-6 months post-implantation 1. After this period, low-dose aspirin is typically sufficient unless additional risk factors are present 1.
B) DOACs have no role in mechanical valve anticoagulation - CORRECT
Direct-acting oral anticoagulants (DOACs) are not recommended for mechanical valves. Vitamin K antagonists (VKAs/coumarins) remain the anticoagulants of choice for all mechanical prosthetic valves 2.
C) Bioprosthetic valve preferred in mitral position for patients <50 years - INCORRECT
This statement contradicts current guidelines. For patients under 50 years of age, mechanical valves are recommended regardless of valve position 3. The evidence is clear:
Predicted 15-year reoperation risk for bioprosthetic valves:
- Age 50: 22%
- Age 40: 30%
- Age 20: 50% 3
ACC/AHA guidelines specifically lowered the age cutoff for mechanical valve preference from 60 to 50 years 3
ESC guidelines recommend mechanical valves for patients <60 years (aortic) and <65 years (mitral) 2
The high structural deterioration rate of bioprosthetic valves in younger patients makes mechanical valves the preferred choice when anticoagulation is feasible 4.
D) Coumarin anticoagulants are the drugs of choice for mechanical valves - CORRECT
Vitamin K antagonists (coumarins/warfarin) are the Class I recommendation for anticoagulation of all mechanical prosthetic valves 2, 1.
E) Target INR is higher for mechanical mitral than aortic valves - CORRECT
Target INR ranges clearly differ by position:
- Mechanical mitral valve: INR 2.5-3.5 (all valve types) 1
- Mechanical aortic valve: INR 2.0-3.0 (bileaflet/Medtronic Hall without risk factors) 1
The mitral position carries higher thrombotic risk, necessitating more intensive anticoagulation 1.
Key Clinical Pitfall
The most common error is choosing bioprosthetic valves in young patients to avoid anticoagulation without adequately counseling them about the near-certainty of requiring reoperation. In patients under 50, the balance strongly favors mechanical valves unless there are absolute contraindications to anticoagulation or strong patient preference after detailed discussion of risks 3, 4.